| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3270137 | HPB | 2010 | 9 Pages |
Abstract
The results of our study demonstrate for the first time that TGF-β displays selective metastasis suppressor activity. These abnormal pathways can serve as selective targets for future development of targeted therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Chandrakanth Are, Neka Simms, Ashwani Rajupt, Michael Brattain,